Hypoxia, inflammation, and the tumor microenvironment in metastatic disease
- PMID: 20393783
- PMCID: PMC4012531
- DOI: 10.1007/s10555-010-9224-5
Hypoxia, inflammation, and the tumor microenvironment in metastatic disease
Abstract
Metastasis, the leading cause of cancer deaths, is an intricate process involving many important tumor and stromal proteins that have yet to be fully defined. This review discusses critical components necessary for the metastatic cascade, including hypoxia, inflammation, and the tumor microenvironment. More specifically, this review focuses on tumor cell and stroma interactions, which allow cell detachment from a primary tumor, intravasation to the blood stream, and extravasation at a distant site where cells can seed and tumor metastases can form. Central players involved in this process and discussed in this review include integrins, matrix metalloproteinases, and soluble growth factors/matrix proteins, including the connective tissue growth factor and lysyl oxidase.
Figures

Similar articles
-
Hypoxia-mediated metastasis.Adv Exp Med Biol. 2014;772:55-81. doi: 10.1007/978-1-4614-5915-6_3. Adv Exp Med Biol. 2014. PMID: 24272354 Review.
-
Proinvasive extracellular matrix remodeling for tumor progression.Arch Pharm Res. 2019 Jan;42(1):40-47. doi: 10.1007/s12272-018-1097-0. Epub 2018 Dec 4. Arch Pharm Res. 2019. PMID: 30515725 Review.
-
Inflammation-mediated promotion of invasion and metastasis.Cancer Metastasis Rev. 2010 Jun;29(2):243-8. doi: 10.1007/s10555-010-9227-2. Cancer Metastasis Rev. 2010. PMID: 20414701 Review.
-
The Extracellular Matrix Modulates the Metastatic Journey.Dev Cell. 2019 May 6;49(3):332-346. doi: 10.1016/j.devcel.2019.03.026. Dev Cell. 2019. PMID: 31063753 Free PMC article. Review.
-
Hypoxia-driven selection of the metastatic phenotype.Cancer Metastasis Rev. 2007 Jun;26(2):319-31. doi: 10.1007/s10555-007-9062-2. Cancer Metastasis Rev. 2007. PMID: 17458507 Review.
Cited by
-
Methods and Techniques to Facilitate the Development of Clostridium novyi NT as an Effective, Therapeutic Oncolytic Bacteria.Front Microbiol. 2021 Mar 29;12:624618. doi: 10.3389/fmicb.2021.624618. eCollection 2021. Front Microbiol. 2021. PMID: 33854487 Free PMC article.
-
CTGF is a therapeutic target for metastatic melanoma.Oncogene. 2014 Feb 27;33(9):1093-100. doi: 10.1038/onc.2013.47. Epub 2013 Feb 25. Oncogene. 2014. PMID: 23435419 Free PMC article.
-
An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic.PLoS One. 2023 Nov 14;18(11):e0289183. doi: 10.1371/journal.pone.0289183. eCollection 2023. PLoS One. 2023. PMID: 37963142 Free PMC article.
-
Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7312-7. doi: 10.1073/pnas.1220998110. Epub 2013 Apr 15. Proc Natl Acad Sci U S A. 2013. PMID: 23589885 Free PMC article.
-
Hypoxia Alleviating PdTe Nanoenzymes for Thermoradiotherapy.Front Bioeng Biotechnol. 2022 Mar 11;9:815185. doi: 10.3389/fbioe.2021.815185. eCollection 2021. Front Bioeng Biotechnol. 2022. PMID: 35360649 Free PMC article.
References
-
- Jemal A, et al. Cancer statistics, 2009. CA: A Cancer Journal for Clinicians. 2009;59(4):225–249. - PubMed
-
- Krug EL, Mjaatvedt CH, Markwald RR. Extracellular matrix from embryonic myocardium elicits an early morphogenetic event in cardiac endothelial differentiation. Developmental Biology. 1987;120(2):348–355. - PubMed
-
- Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anatomica (Basel) 1995;154(1):8–20. - PubMed
-
- Tarin D, Thompson EW, Newgreen DF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Research. 2005;65(14):5996–6000. discussion 6000-1. - PubMed
-
- Birchmeier W, Behrens J. Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness. Biochimica et Biophysica Acta. 1994;1198(1):11–26. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources